Radiologists Need to Become Central Members of Cancer Teams
By MedImaging International staff writers Posted on 08 Aug 2016 |
Image: Radiologists can ensure their role as central members of the cancer team with a better understanding of imaging-evident drug toxicity (Photo courtesy of the Dana Farber Cancer Institute).
Radiologists need to become established as central members of cancer teams because of an expected increase in the importance of imaging for cancer between the years 2016 and 2026. Radiologists are responsible for early identification of toxicity using precision oncology imaging, and need to interpret these findings, including the relationship of the findings with tumor response, and the effect on metastasectomy.
The review article was published in the July 2016 issue of the American Journal of Roentgenology by radiologists and researchers at the Dana Farber Cancer Institute radiology department (Boston, MA, USA). The purpose of the article is to help radiologists understand imaging-evident toxicity.
Oncologists are using new cytotoxic agents, and new drug combinations to control cancer, but these can lead to increased toxicity, sometimes with unpredictable outcomes. The study intends to guide radiologists how to deal with changes in toxicity in imaging findings.
Study leader, Stephanie A. Holler Howard, Department of Radiology, Dana Farber Cancer Institute (Boston, USA), said, "This article attempts to expand the radiologist's view of the effect of imaging-evident toxicity by delineating how oncologists grade toxicity, highlighting the potential relationship between toxicity and drug efficacy, discussing how toxicity affects patients who may ultimately undergo metastasectomy, and exploring the effect of combining multiple drug classes on severity of adverse events. Radiologists must understand the language and multifaceted nuances of toxicity to contribute to optimized care of cancer patients and remain relevant effective members of the oncologic team."
Related Links:
Dana Farber Cancer Institute
The review article was published in the July 2016 issue of the American Journal of Roentgenology by radiologists and researchers at the Dana Farber Cancer Institute radiology department (Boston, MA, USA). The purpose of the article is to help radiologists understand imaging-evident toxicity.
Oncologists are using new cytotoxic agents, and new drug combinations to control cancer, but these can lead to increased toxicity, sometimes with unpredictable outcomes. The study intends to guide radiologists how to deal with changes in toxicity in imaging findings.
Study leader, Stephanie A. Holler Howard, Department of Radiology, Dana Farber Cancer Institute (Boston, USA), said, "This article attempts to expand the radiologist's view of the effect of imaging-evident toxicity by delineating how oncologists grade toxicity, highlighting the potential relationship between toxicity and drug efficacy, discussing how toxicity affects patients who may ultimately undergo metastasectomy, and exploring the effect of combining multiple drug classes on severity of adverse events. Radiologists must understand the language and multifaceted nuances of toxicity to contribute to optimized care of cancer patients and remain relevant effective members of the oncologic team."
Related Links:
Dana Farber Cancer Institute
Latest General/Advanced Imaging News
- Bone Density Test Uses Existing CT Images to Predict Fractures
- AI Predicts Cardiac Risk and Mortality from Routine Chest CT Scans
- Radiation Therapy Computed Tomography Solution Boosts Imaging Accuracy
- PET Scans Reveal Hidden Inflammation in Multiple Sclerosis Patients
- Artificial Intelligence Evaluates Cardiovascular Risk from CT Scans
- New AI Method Captures Uncertainty in Medical Images
- CT Coronary Angiography Reduces Need for Invasive Tests to Diagnose Coronary Artery Disease
- Novel Blood Test Could Reduce Need for PET Imaging of Patients with Alzheimer’s
- CT-Based Deep Learning Algorithm Accurately Differentiates Benign From Malignant Vertebral Fractures
- Minimally Invasive Procedure Could Help Patients Avoid Thyroid Surgery
- Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery
- AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning
- Imaging Technology Provides Ground-Breaking New Approach for Diagnosing and Treating Bowel Cancer
- CT Coronary Calcium Scoring Predicts Heart Attacks and Strokes
- AI Model Detects 90% of Lymphatic Cancer Cases from PET and CT Images
- Breakthrough Technology Revolutionizes Breast Imaging